Topicort and Medrol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Topicort (desoximetasone) and Medrol (methylprednisolone). Common drug interactions include gastric ulcer among females and angina unstable among males.
The phase IV clinical study analyzes what interactions people have when they take Topicort and Medrol. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Topicort?
Topicort has active ingredients of desoximetasone. eHealthMe is studying from 3,423 Topicort users. Check the latest studies of Topicort.
What is Medrol?
Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
16 people who take Topicort and Medrol together, and have interactions are studied.

What are the common drug interactions of Topicort and Medrol, by gender? *:
female:
- Gastric ulcer (stomach ulcer)
- Gastritis (inflammation of stomach)
- Heart rate irregular
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Hyperkeratosis (thickening of the outer layer of the skin)
- Hypertension (high blood pressure)
- Hypotension (abnormally low blood pressure)
- Ill-defined disorder
- Injury
- Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)
male:
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
- Back pain
- Eye pruritus (eye itching)
- Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
- Hypercholesterolaemia (high levels of cholesterol in the blood)
- Hypertension (high blood pressure)
- Hypertriglyceridaemia (excess of triglycerides in the blood)
- Joint injury
- Nausea (feeling of having an urge to vomit)
- Neck injury
What are the common drug interactions of Topicort and Medrol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
- Back pain
- Cardiac disorder
- Chest pain
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Anaphylactic reaction (serious allergic reaction)
- Arteriosclerosis (thickening and hardening of arteries)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Cyst (a closed sac)
- Dyspepsia (indigestion)
50-59:
- Therapeutic response unexpected
60+:
- Pruritus (severe itching of the skin)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Influenza
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Throat irritation
- Vomiting
- Abdominal discomfort
- Abdominal pain
- Adverse drug reaction
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
What are the existing conditions these people have? *
- Migraine (headache): 2 people, 12.50%
- Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 2 people, 12.50%
- Hypersensitivity: 2 people, 12.50%
- Pain: 1 person, 6.25%
- Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 6.25%
- Itching: 1 person, 6.25%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 6.25%
- Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 6.25%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.25%
- Dermatitis Allergic (inflammation of the skin due allergic reaction): 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Topicort and Medrol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Topicort and Medrol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Topicort:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Medrol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Topicort and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Medrol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on desoximetasone and methylprednisolone (the active ingredients of Topicort and Medrol, respectively), and Topicort and Medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tooth Abscess and drugs of ingredients of ferrous fumarate - a second ago
- Metoprolol Tartrate and Incontinence for Women aged 60+ - 4 seconds ago
- Methotrexate and Hypergammaglobulinaemia Benign Monoclonal for Women aged 40-49 - 4 seconds ago
- Patellofemoral Pain Syndrome and drugs of ingredients of hydroxyzine hydrochloride - 4 seconds ago
- Renal Pain and drugs of ingredients of pravastatin sodium - 4 seconds ago
- Ibrance and Hair Loss for Men aged 60+ - 15 seconds ago
- Ibrance and Hair Thinning for Men aged 60+ - 16 seconds ago
- Ibrance and Hairloss for Men aged 60+ - 16 seconds ago
- Ibrance and Baldness for Men aged 60+ - 16 seconds ago
- Ibrance and Alopecia for Men aged 60+ - 17 seconds ago